Brief: Brainstorm Cell Therapeutics Announces First Quarter 2023 Financial Results
15/05/2023 12:16
May 15 (Reuters) - Brainstorm Cell Therapeutics Inc
BCLI.O :
* BRAINSTORM CELL THERAPEUTICS ANNOUNCES FIRST QUARTER 2023
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* BRAINSTORM CELL THERAPEUTICS INC- QTRLY LOSS PER SHARE
$0.14
Source text for Eikon: ID:nPn8nWfP6a
Further company coverage: BCLI.O
Recent news on Brainstorm Cell Therapeutics
See all newsBrief: Brainstorm Appoints Former FDA Associate Commissioner Peter J. Pitts As Executive Chairman
Brief: Brainstorm Cell Therapeutics Announces First Quarter 2026 Financial Results And Provides Corporate Update
Brief: Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing At Premium To Market
Brief: Brainstorm Cell Therapeutics Announces Second Quarter Financial Results
Brainstorm Cell Therapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview